Abstract
Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life-threatening arrhythmia.
Original language | English |
---|---|
Pages (from-to) | 391-394 |
Number of pages | 4 |
Journal | Clinical Case Reports |
Volume | 9 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2021 |
Bibliographical note
Publisher Copyright:© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Keywords
- QT prolongation
- amiodarone
- atrial fibrillation
- torsades de Pointes